erythromycin has been researched along with nab741 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hussain, Z; Li, Y; Li, Z; Liu, S; Liu, Y; She, P; Wu, Y; Xu, L | 1 |
| Hussain, Z; Li, L; Li, Y; Li, Z; Liu, S; Liu, Y; She, P; Wu, Y; Xu, L; Yang, Y | 1 |
2 other study(ies) available for erythromycin and nab741
| Article | Year |
|---|---|
SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant
Topics: Animals; Antimicrobial Cationic Peptides; Biofilms; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests | 2022 |
Triple combination of SPR741, clarithromycin, and erythromycin against Acinetobacter baumannii and its tolerant phenotype.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Biofilms; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Microbial Sensitivity Tests | 2023 |